Prevalence and Patterns of Cranial Nerve Involvement in CIDP, Autoimmune Nodopathy, MMN, and Anti‐MAG Neuropathy: A Multicenter Korea/UK Study of 582 Patients.
Saved in:
| Title: | Prevalence and Patterns of Cranial Nerve Involvement in CIDP, Autoimmune Nodopathy, MMN, and Anti‐MAG Neuropathy: A Multicenter Korea/UK Study of 582 Patients. |
|---|---|
| Authors: | Min, Young Gi (AUTHOR), Kim, Hyunjin (AUTHOR), Han, Hee Jo (AUTHOR), Yoon, Byeol‐A (AUTHOR), Kim, Jong Kuk (AUTHOR), Ju, Woohee (AUTHOR), Choi, Seok‐Jin (AUTHOR), Kim, Sung‐Min (AUTHOR), Kim, Ki Hoon (AUTHOR), Kwon, Young Nam (AUTHOR), Kim, Seung Woo (AUTHOR), Lee, Eun‐Jae (AUTHOR), Lim, Young‐Min (AUTHOR), Nazeer, Kabir K. (AUTHOR), Rajabally, Yusuf A. (AUTHOR), Shin, Ha Young (AUTHOR), Sung, Jung‐Joon (AUTHOR) |
| Source: | European Journal of Neurology. Feb2026, Vol. 33 Issue 2, p1-8. 8p. |
| Subjects: | Cranial nerves, Chronic inflammatory demyelinating polyradiculoneuropathy, Guillain-Barré syndrome, Optic nerve diseases, Facial paralysis, Trigeminal nerve diseases |
| Abstract: | Background: Cranial nerve involvement is a well‐recognized feature in Guillain–Barré syndrome (GBS) but remains less well understood in chronic forms of autoimmune neuropathies. Earlier studies of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) were conducted before updated diagnostic criteria and the recognition of autoimmune nodopathy (AN), which may limit the interpretation of their findings. Methods: We retrospectively analyzed 582 patients with chronic autoimmune neuropathies—CIDP (n = 431), multifocal motor neuropathy (MMN) (n = 64), anti‐myelin‐associated glycoprotein (MAG) neuropathy (n = 54), and AN (n = 33)—from 4 Korean and 1 UK centers. Patients with cranial nerve involvement were identified and described. CIDP patients with cranial nerve involvement (cranial+ CIDP) were compared with those without (cranial− CIDP). Results: Cranial nerve involvement was observed in 8.8% (38/431) of CIDP and 24.2% (8/33) of AN patients but was absent in MMN (0/64) and anti‐MAG neuropathy (0/54). Facial palsy was overall the most common manifestation (CIDP: 45%, AN: 50%). Patients with AN more frequently exhibited bilateral optic neuropathy (50%) and facial diplegia (38%), while CIDP patients more often showed trigeminal neuropathy and oculomotor nerve palsy (both 32%). Compared with cranial− CIDP, cranial+ CIDP patients were more often younger, of variant subtypes (especially multifocal), presented (sub)acutely with preceding infection/vaccination, followed by relapsing–remitting rather than progressive courses, and achieved greater improvement despite greater pre‐treatment disability. Conclusions: Cranial nerve involvement serves as a diagnostic clue in chronic autoimmune neuropathies, particularly in identifying AN and CIDP. Cranial+ CIDP appears to represent a distinct subset with partial overlap to GBS, suggesting unique underlying mechanisms. [ABSTRACT FROM AUTHOR] |
| Copyright of European Journal of Neurology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Background: Cranial nerve involvement is a well‐recognized feature in Guillain–Barré syndrome (GBS) but remains less well understood in chronic forms of autoimmune neuropathies. Earlier studies of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) were conducted before updated diagnostic criteria and the recognition of autoimmune nodopathy (AN), which may limit the interpretation of their findings. Methods: We retrospectively analyzed 582 patients with chronic autoimmune neuropathies—CIDP (n = 431), multifocal motor neuropathy (MMN) (n = 64), anti‐myelin‐associated glycoprotein (MAG) neuropathy (n = 54), and AN (n = 33)—from 4 Korean and 1 UK centers. Patients with cranial nerve involvement were identified and described. CIDP patients with cranial nerve involvement (cranial+ CIDP) were compared with those without (cranial− CIDP). Results: Cranial nerve involvement was observed in 8.8% (38/431) of CIDP and 24.2% (8/33) of AN patients but was absent in MMN (0/64) and anti‐MAG neuropathy (0/54). Facial palsy was overall the most common manifestation (CIDP: 45%, AN: 50%). Patients with AN more frequently exhibited bilateral optic neuropathy (50%) and facial diplegia (38%), while CIDP patients more often showed trigeminal neuropathy and oculomotor nerve palsy (both 32%). Compared with cranial− CIDP, cranial+ CIDP patients were more often younger, of variant subtypes (especially multifocal), presented (sub)acutely with preceding infection/vaccination, followed by relapsing–remitting rather than progressive courses, and achieved greater improvement despite greater pre‐treatment disability. Conclusions: Cranial nerve involvement serves as a diagnostic clue in chronic autoimmune neuropathies, particularly in identifying AN and CIDP. Cranial+ CIDP appears to represent a distinct subset with partial overlap to GBS, suggesting unique underlying mechanisms. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 13515101 |
| DOI: | 10.1111/ene.70512 |
